{"id":473112,"date":"2021-04-07T14:03:23","date_gmt":"2021-04-07T18:03:23","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=473112"},"modified":"2021-04-07T14:03:23","modified_gmt":"2021-04-07T18:03:23","slug":"ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/","title":{"rendered":"Ram Mullur Joins CNL as New Vice-President of Isotope Business"},"content":{"rendered":"

\nCanada\u2019s national nuclear laboratory welcomes accomplished senior executive to grow its commercial business in medical isotopes and radiopharmaceuticals
\n<\/h2>\n
\n

CHALK RIVER, Ontario, April 07, 2021 (GLOBE NEWSWIRE) — Canadian Nuclear Laboratories (CNL), Canada\u2019s premier nuclear science and technology organization, is pleased to announce that Ram Mullur has joined the organization as its new Vice-President of Isotope Business. Mr. Mullur is an accomplished executive with more than 25 years of broad industry experience and a thorough understanding of the medical isotopes and radiopharmaceuticals landscape, and will work to grow CNL\u2019s leadership position in the development and supply of medical and industrial isotopes.<\/p>\n

With over one billion treatments conducted using isotopes produced at the Chalk River Laboratories campus, CNL has been a world leader in the production of medical isotopes for decades. As part of its Vision 2030 plan, CNL is leveraging this expertise to become an international hub in the research, development and supply of the next-generation of medical isotopes and radiopharmaceuticals, including actinium-225, a rare isotope that shows great promise as the basis for new, cutting-edge cancer therapies.<\/p>\n

\u201cGiven his leadership and industry experience, we believe Ram will be an exceptional addition to CNL as we pursue the next-generation of medical isotopes and radiopharmaceuticals at our Chalk River Laboratories campus,\u201d commented Joe McBrearty, CNL\u2019s President and CEO. \u201cRam has a deep understanding of the Canadian and international radiopharmaceutical market, with expertise that spans development to distribution, and his leadership will help us navigate production pathways for actinium-225 and the commercialization of other promising isotopes.\u201d<\/p>\n

Among his responsibilities as Vice-President of Isotope Business, Mr. Mullur will lead CNL\u2019s efforts to pursue commercial opportunities related to actinium-225, a rare medical isotope that shows great promise as the basis for new, cutting-edge cancer therapies. An alpha-emitting isotope with a short half-life, actinium-225 can be combined with a protein or antibody that specifically targets and kills cancer cells, leaving the surrounding healthy tissue unharmed. With a short half-life of just ten days, the actinium then decays without accumulating in a patient\u2019s body.<\/p>\n

Known as targeted alpha therapy, this form of treatment has shown exciting potential in early studies with prostate cancer patients for whom conventional cancer therapies have not worked. Researchers are eager to try this targeted alpha therapy approach with a wide range of cancers. However, current global supplies of actinium-225 would only be enough to treat a handful of patients every year, leading the isotope to be nicknamed, \u201cthe rarest drug on Earth.\u201d CNL\u2019s Chalk River Laboratories campus is one of only a few locations in the world with a thorium generator that can produce this material in research-scale quantities.<\/p>\n

\u201cCNL has a strong reputation as a world leader in the production and processing of medical isotopes, and I\u2019m incredibly excited to join the team and help build on this legacy,\u201d commented Mr. Mullur. \u201cIn particular, I believe that CNL\u2019s research in targeted alpha therapy and actinium-225 holds great promise in the development of new and innovative medical breakthroughs to fight cancer. It is this ambitious program of work that drew me to the position, and I can\u2019t wait to get started.\u201d<\/p>\n

Prior to his arrival at CNL, Ram served as the Director and Head of Business Development at a leading radiopharmaceutical company, where he was responsible for expanding its commercial business into new products and technologies in the nuclear medicine and radiopharmaceutical field. This experience included leading acquisition, investment and licensing initiatives, negotiating business contracts and pursuing strategic partnerships and collaborations. Among his many accomplishments, Ram helped advance key products in the company\u2019s development pipeline to their commercial phase and was instrumental in the growth of its new product portfolio. Ram also shaped, negotiated and helped complete external business partnerships for novel radiopharmaceutical products.<\/p>\n

Ram has also served in leadership positions at other health sciences and industrial companies as a global brand manager, production operations manager, and quality and plant operations manager. He completed his MBA at McGill University, holds a M.Sc. in Chemistry and is certified in Canadian Risk Management.<\/p>\n

For more information on CNL, including its leadership team, please visit www.cnl.ca<\/a>.<\/p>\n

\n About CNL <\/strong>\n <\/p>\n

Canadian Nuclear Laboratories is a world leader in nuclear science and technology offering unique capabilities and solutions across a wide range of industries. Actively involved with industry-driven research and development in nuclear, transportation, clean technology, energy, defence, security and life sciences, we provide solutions to keep these sectors competitive internationally.<\/p>\n

With ongoing investments in new facilities and a focused mandate, Canadian Nuclear Laboratories is well positioned for the future. A new performance standard reinforced with a strong safety culture underscores every activity.<\/p>\n

For more information on the complete range of Canadian Nuclear Laboratories services, please visit www.cnl.ca<\/a> or contact communications@cnl.ca<\/a>.<\/p>\n

\n CNL Contact:<\/strong>
\n
Patrick Quinn
Director, Corporate Communications
CNL, 1-866-886-2325<\/p>\n

A photo accompanying this announcement is available at https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/40d61cd0-5531-4995-9463-5733a437ff42<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Canada\u2019s national nuclear laboratory welcomes accomplished senior executive to grow its commercial business in medical isotopes and radiopharmaceuticals CHALK RIVER, Ontario, April 07, 2021 (GLOBE NEWSWIRE) — Canadian Nuclear Laboratories (CNL), Canada\u2019s premier nuclear science and technology organization, is pleased to announce that Ram Mullur has joined the organization as its new Vice-President of Isotope Business. Mr. Mullur is an accomplished executive with more than 25 years of broad industry experience and a thorough understanding of the medical isotopes and radiopharmaceuticals landscape, and will work to grow CNL\u2019s leadership position in the development and supply of medical and industrial isotopes. With over one billion treatments conducted using isotopes produced at the Chalk River Laboratories campus, CNL has been a world … <\/p>\n

Continue reading “Ram Mullur Joins CNL as New Vice-President of Isotope Business”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-473112","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nRam Mullur Joins CNL as New Vice-President of Isotope Business - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ram Mullur Joins CNL as New Vice-President of Isotope Business - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Canada\u2019s national nuclear laboratory welcomes accomplished senior executive to grow its commercial business in medical isotopes and radiopharmaceuticals CHALK RIVER, Ontario, April 07, 2021 (GLOBE NEWSWIRE) — Canadian Nuclear Laboratories (CNL), Canada\u2019s premier nuclear science and technology organization, is pleased to announce that Ram Mullur has joined the organization as its new Vice-President of Isotope Business. Mr. Mullur is an accomplished executive with more than 25 years of broad industry experience and a thorough understanding of the medical isotopes and radiopharmaceuticals landscape, and will work to grow CNL\u2019s leadership position in the development and supply of medical and industrial isotopes. With over one billion treatments conducted using isotopes produced at the Chalk River Laboratories campus, CNL has been a world … Continue reading "Ram Mullur Joins CNL as New Vice-President of Isotope Business"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-07T18:03:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMzEwOSM0MTEwMzI5IzIwOTM5NjE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ram Mullur Joins CNL as New Vice-President of Isotope Business\",\"datePublished\":\"2021-04-07T18:03:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/\"},\"wordCount\":838,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMzEwOSM0MTEwMzI5IzIwOTM5NjE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/\",\"name\":\"Ram Mullur Joins CNL as New Vice-President of Isotope Business - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMzEwOSM0MTEwMzI5IzIwOTM5NjE=\",\"datePublished\":\"2021-04-07T18:03:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMzEwOSM0MTEwMzI5IzIwOTM5NjE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMzEwOSM0MTEwMzI5IzIwOTM5NjE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ram Mullur Joins CNL as New Vice-President of Isotope Business\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ram Mullur Joins CNL as New Vice-President of Isotope Business - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/","og_locale":"en_US","og_type":"article","og_title":"Ram Mullur Joins CNL as New Vice-President of Isotope Business - Market Newsdesk","og_description":"Canada\u2019s national nuclear laboratory welcomes accomplished senior executive to grow its commercial business in medical isotopes and radiopharmaceuticals CHALK RIVER, Ontario, April 07, 2021 (GLOBE NEWSWIRE) — Canadian Nuclear Laboratories (CNL), Canada\u2019s premier nuclear science and technology organization, is pleased to announce that Ram Mullur has joined the organization as its new Vice-President of Isotope Business. Mr. Mullur is an accomplished executive with more than 25 years of broad industry experience and a thorough understanding of the medical isotopes and radiopharmaceuticals landscape, and will work to grow CNL\u2019s leadership position in the development and supply of medical and industrial isotopes. With over one billion treatments conducted using isotopes produced at the Chalk River Laboratories campus, CNL has been a world … Continue reading \"Ram Mullur Joins CNL as New Vice-President of Isotope Business\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-07T18:03:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMzEwOSM0MTEwMzI5IzIwOTM5NjE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ram Mullur Joins CNL as New Vice-President of Isotope Business","datePublished":"2021-04-07T18:03:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/"},"wordCount":838,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMzEwOSM0MTEwMzI5IzIwOTM5NjE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/","name":"Ram Mullur Joins CNL as New Vice-President of Isotope Business - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMzEwOSM0MTEwMzI5IzIwOTM5NjE=","datePublished":"2021-04-07T18:03:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMzEwOSM0MTEwMzI5IzIwOTM5NjE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMzEwOSM0MTEwMzI5IzIwOTM5NjE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ram-mullur-joins-cnl-as-new-vice-president-of-isotope-business\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ram Mullur Joins CNL as New Vice-President of Isotope Business"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/473112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=473112"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/473112\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=473112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=473112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=473112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}